Graves’ disease is the single most common cause of hyperthyroidism, responsible for 60% to 80% of all cases. The two terms aren’t interchangeable, though. Hyperthyroidism is a state where the thyroid gland produces more hormones than the body needs. Graves’ disease is one specific reason that happens.
How Graves’ Disease Causes Hyperthyroidism
Graves’ disease is an autoimmune disorder. Your immune system produces antibodies that latch onto receptors on the thyroid gland, the same receptors normally activated by a brain signal telling the thyroid to produce hormones. These antibodies mimic that signal but can’t be turned off the way the brain’s signal can. The result is a thyroid that runs continuously, flooding the body with excess thyroid hormone.
This makes Graves’ disease fundamentally different from other causes of hyperthyroidism. In toxic multinodular goiter, for example, lumps on the thyroid independently produce extra hormone. In thyroiditis, inflammation damages thyroid tissue and stored hormone leaks into the bloodstream temporarily. In Graves’ disease, the entire gland is being driven into overdrive by the immune system itself.
Symptoms Shared With All Hyperthyroidism
Because Graves’ disease produces the same excess thyroid hormones as other forms of hyperthyroidism, many symptoms overlap. You may experience a rapid or irregular heartbeat, unintentional weight loss, anxiety, trembling hands, heat intolerance, and frequent bowel movements. These are all consequences of too much thyroid hormone speeding up the body’s metabolism, regardless of the underlying cause.
Symptoms Unique to Graves’ Disease
What sets Graves’ disease apart are a few distinctive physical signs that don’t appear in other types of hyperthyroidism.
About 25% of people with Graves’ disease develop eye problems, sometimes called Graves’ eye disease. The immune attack extends beyond the thyroid to tissues around the eyes, causing bulging eyes, redness, a gritty sensation, puffy or retracted eyelids, light sensitivity, and sometimes double or blurred vision. In severe cases, vision loss can occur. This is the hallmark that most clearly distinguishes Graves’ from other hyperthyroid conditions.
Rarely, a skin change called Graves’ dermopathy develops, usually on the shins and tops of the feet. The skin darkens, thickens, and takes on a texture similar to orange peel. It’s caused by protein buildup in the skin and is typically mild and painless.
How Doctors Tell It’s Graves’ Disease
When blood tests show suppressed levels of thyroid-stimulating hormone (TSH) alongside elevated thyroid hormones, that confirms hyperthyroidism. The next step is figuring out why.
A blood test for thyroid receptor antibodies is the most reliable way to confirm Graves’ disease specifically. These antibodies are elevated in untreated Graves’ disease, and the test has a sensitivity and specificity around 95%, approaching 100% with newer testing methods.
If more clarity is needed, a radioactive iodine uptake scan can distinguish Graves’ from other causes. In Graves’ disease, the entire thyroid lights up uniformly because the whole gland is being stimulated. In toxic multinodular goiter, the scan shows a patchy pattern of “hot” and “cold” spots where individual nodules are active or inactive.
What Drives the Risk
Graves’ disease results from a combination of genetic susceptibility and environmental triggers. It runs in families and is far more common in women. Emotional stress and high dietary iodine intake are recognized risk factors.
Smoking stands out as especially significant. It’s the strongest known risk factor for developing Graves’ eye disease, and the risk climbs with the number of cigarettes smoked per day. Research shows that cigarette smoke amplifies the immune response in people with Graves’ disease, increasing the activity of inflammatory molecules and the proliferation of immune cells that drive the condition.
Treatment and Remission Rates
Treatment for Graves’ disease targets the excess hormone production. Antithyroid medications are typically the first approach, blocking the thyroid from producing as much hormone. Clinical guidelines recommend a treatment course of 12 to 18 months, though some patients benefit from longer courses.
Remission rates vary widely. After a standard 12 to 18 months of medication, remission rates in the United States sit around 20% to 30%. In Europe, where longer treatment courses of 5 to 6 years are more common, rates reach 50% to 60%. The pattern is clear: longer treatment reduces the chance of relapse. Patients treated for 1 to 2 years see a relapse rate around 53%, while those treated for 6 to 10 years see it drop to about 15%.
When medication doesn’t achieve lasting remission, the other main options are radioactive iodine therapy, which shrinks the thyroid by destroying overactive tissue, and surgery to remove part or all of the gland. Both of these typically result in an underactive thyroid afterward, requiring lifelong thyroid hormone replacement pills. That trade-off, from overactive to underactive, is generally considered easier to manage long term.
Thyroid Storm: A Rare but Serious Risk
Thyroid storm is a dangerous escalation of hyperthyroidism where hormone levels spike to life-threatening levels. It accounts for about 1% to 2% of hospital admissions for hyperthyroidism. Common triggers include suddenly stopping antithyroid medication, surgery, acute infections (including COVID-19), severe emotional distress, and trauma. Symptoms include very high fever, rapid heart rate, confusion, and agitation. It requires emergency treatment.
Thyroid storm is rare, but it’s the reason consistent treatment matters. People with Graves’ disease who abruptly stop their medication are at particular risk.
The Bottom Line on the Relationship
Every person with Graves’ disease has hyperthyroidism (at least when the disease is active and untreated), but not every person with hyperthyroidism has Graves’ disease. Graves’ is one cause of hyperthyroidism, just the most common one. The autoimmune mechanism behind it creates unique complications, particularly in the eyes, that other forms of hyperthyroidism don’t produce, and it requires treatment strategies aimed at both controlling hormone levels and managing the underlying immune dysfunction.